Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 21:00:02 26/04/2024 BST 		5-day change 1st Jan Change
18.55 USD +0.71% Intraday chart for Organon & Co. +4.10% +28.64%
04-09 Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating MT
04-08 Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint MT

Chart calendar Organon & Co.

af87.I8GUfrdyctSYrkEfNQY8p-FBlPquLuB5H4xU2H2WyRI.UbjCFfY9H4f-7x5yYXBq4qIe7aztd5NAXroFlyv6m3FCjNIv5x035676cQ~e0650ef66a98cd776f390cc31bef0445

Upcoming events on Organon & Co.

02/05/2024 12:30 Q1 2024 Earnings Release
02/05/2024 13:30 Q1 2024 Earnings Call
06/08/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
12/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Organon & Co.

15/02/2024 13:30 Q4 2023 Earnings Call
15/02/2024 12:30 Q4 2023 Earnings Release
09/01/2024 21:30 JPMorgan Healthcare Conference
29/11/2023 16:00 Piper Sandler Healthcare Conference - Fireside Chat
02/11/2023 12:30 Q3 2023 Earnings Call
02/11/2023 11:30 Q3 2023 Earnings Release
08/08/2023 13:30 Q2 2023 Earnings Call
08/08/2023 12:30 Q2 2023 Earnings Release
06/06/2023 14:00 Annual General Meeting
04/05/2023 13:30 Q1 2023 Earnings Call
04/05/2023 12:30 Q1 2023 Earnings Release
16/02/2023 13:30 FY 2022 Earnings Call
16/02/2023 12:30 FY 2022 Earnings Release
10/01/2023 15:30 JP Morgan Healthcare Conference - Fireside Chat
29/11/2022 14:00 Piper Sandler Healthcare Conference - Fireside Chat
03/11/2022 12:30 Q3 2022 Earnings Call
03/11/2022 11:30 Q3 2022 Earnings Release
04/08/2022 13:30 Interim 2022 Earnings Call
04/08/2022 12:30 Interim 2022 Earnings Release
07/06/2022 14:00 Annual General Meeting

Past dividends on Organon & Co.

22/02/2024 Quarterly 0.28 USD
09/11/2023 Quarterly 0.28 USD
16/08/2023 Quarterly 0.28 USD
11/05/2023 Quarterly 0.28 USD
23/02/2023 Quarterly 0.28 USD
09/11/2022 Quarterly 0.28 USD
11/08/2022 Quarterly 0.28 USD
12/05/2022 Quarterly 0.28 USD
24/02/2022 Quarterly 0.28 USD
18/11/2021 Quarterly 0.28 USD

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		8 096


6 304
6 280
0.38%		6 174
6 186
-0.19%		6 263
6 214
0.79%
6 373

EBITDA
Million USD		Released
Forecast
Spread 		0,00


2 379
2 287
4.01%		2 085
2 104
-0.91%		1 944
1 921
1.22%
1 998

EBIT
Million USD		Released
Forecast
Spread 		0,00


2 184
2 239
-2.48%		1 873
1 971
-4.99%		1 874
1 803
3.93%
1 868

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


1 529
1 712
-10.69%		1 122
1 173
-4.35%		673
929
-27.56%
0,00

Net income
Million USD		Released
Forecast
Spread 		2 160


1 351
1 484
-8.96%		917
941
-2.55%		1 023
602
69.93%
788

EPS
USD		Released
Forecast
Spread 		0,00


5,31
5,98
-11.2%		3,59
3,71
-3.15%		3,99
2,35
69.79%
3,04

Announcement Date14/04/2117/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		1 604
1 580
1.5%		1 567
1 519
3.14%		1 585
1 532
3.49%		1 537
1 516
1.39%		1 485
1 495
-0.7%		1 538
1 538
-0.02%		1 608
1 557
3.3%		1 519
1 572
-3.39%		1 598
1 481
7.87%
1 561


1 629


1 564


1 607


1 560

EBITDA
Million USD		Released
Forecast
Spread 		549
533
2.94%		647
512
26.38%		512
474
8.1%		546
469
16.52%		380
423
-10.21%		518
535
-3.26%		530
462
14.7%		447
493
-9.4%		449
412
8.96%
451


515


515


527




EBIT
Million USD		Released
Forecast
Spread 		487
479
1.68%		594
501
18.51%		462
456
1.35%		489
446
9.54%		328
398
-17.56%		461
487
-5.3%		472
438
7.69%		430
468
-8.03%		436
405
7.67%
438


479


482


498




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		236
419
-43.68%


287
348
-17.53%		282
256
10.16%		111
170
-34.71%		235
282
-16.67%		254
275
-7.64%		80,0
238
-66.39%		104
202
-48.51%














Net income
Million USD		Released
Forecast
Spread 		202
335
-39.7%


234
284
-17.61%		227
209
8.61%		108
139
-22.3%		177
226
-21.68%		242
220
10%		58,0
191
-69.63%		546
162
237.04%














EPS
USD		Released
Forecast
Spread 		0,79
1,11
-28.83%		1,36
0,98
38.78%		0,92
0,92
0.55%		0,89
0,82
8.54%		0,42
0,56
-25%		0,69
0,95
-27.37%		0,95
0,86
10.47%		0,23
0,74
-68.92%		2,13
0,63
238.1%














Announcement Date17/02/2205/05/2204/08/2203/11/2216/02/2304/05/2308/08/2302/11/2315/02/24-----

Upcoming sector events for Organon & Co.

28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
28/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
28/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Organon & Co.

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Calendar Organon & Co.